Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Medtronic
Harvard Business School
McKesson
Express Scripts

Last Updated: January 17, 2020

DrugPatentWatch Database Preview

CHILDREN'S ADVIL COLD Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Children's Advil Cold, and when can generic versions of Children's Advil Cold launch?

Children's Advil Cold is a drug marketed by Glaxosmithkline and is included in one NDA.

The generic ingredient in CHILDREN'S ADVIL COLD is ibuprofen; pseudoephedrine hydrochloride. There are sixty-four drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the ibuprofen; pseudoephedrine hydrochloride profile page.

Summary for CHILDREN'S ADVIL COLD
Drug patent expirations by year for CHILDREN'S ADVIL COLD
Recent Clinical Trials for CHILDREN'S ADVIL COLD

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Douglas FraserPhase 3
Y-mAbs TherapeuticsPhase 1/Phase 2
Global Alliance for TB Drug DevelopmentPhase 1

See all CHILDREN'S ADVIL COLD clinical trials

Synonyms for CHILDREN'S ADVIL COLD
473545-41-4
CHILDREN'S MOTRIN COLD
DTXSID70197118
Ibuprofen / pseudoephedrine hydrochloride
Ibuprofen and pseudoephedrine hydrochloride
Ibuprofen mixture with pseudoephedrine hydrochloride
IBUPROHM COLD AND SINUS
SINE-AID IB

US Patents and Regulatory Information for CHILDREN'S ADVIL COLD

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline CHILDREN'S ADVIL COLD ibuprofen; pseudoephedrine hydrochloride SUSPENSION;ORAL 021373-001 Apr 18, 2002 OTC No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Express Scripts
Mallinckrodt
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.